CBIZ (CBZ) Stock Forecast, Price & News

CBIZ's stock was trading at $46.85 on January 1st, 2023. Since then, CBZ stock has increased by 7.1% and is now trading at $50.16.
View the best growth stocks for 2023 here.

CBIZ saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 577,300 shares, an increase of 24.6% from the April 30th total of 463,200 shares. Based on an average daily trading volume, of 213,200 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.2% of the company's stock are short sold.
View CBIZ's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our CBZ earnings forecast.

CBIZ, Inc. (NYSE:CBZ) released its earnings results on Thursday, April, 27th. The business services provider reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.17. The business services provider earned $454.60 million during the quarter, compared to analyst estimates of $432.66 million. CBIZ had a net margin of 8.16% and a trailing twelve-month return on equity of 16.24%. The firm's revenue was up 16.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.18 EPS.

ETFs with the largest weight of CBIZ (NYSE:CBZ) stock in their portfolio include Argent Mid Cap ETF (AMID), Profound Medical (PRN), First Trust Small Cap Growth AlphaDEX Fund (FYC), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Janus Henderson Small Cap Growth Alpha ETF (JSML), First Trust Active Factor Small Cap ETF (AFSM), Invesco DWA SmallCap Momentum ETF (DWAS) and

CBIZ issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $2.36-$2.41 for the period, compared to the consensus EPS estimate of $2.36. The company issued revenue guidance of $1.52 billion-$1.55 billion, compared to the consensus revenue estimate of $1.54 billion.

57 employees have rated CBIZ Chief Executive Officer Jerry Grisko on Glassdoor.com. Jerry Grisko has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other CBIZ investors own include Walt Disney (DIS), Veracyte (VCYT), Carnival Co. & (CCL), CRISPR Therapeutics (CRSP), Etsy (ETSY), Gilead Sciences (GILD), Johnson & Johnson (JNJ), KeyCorp (KEY), Altria Group (MO) and NeoGenomics (NEO).

CBIZ trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBZ."

CBIZ's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (6.46%), Dimensional Fund Advisors LP (6.37%), FIL Ltd (3.73%), Burgundy Asset Management Ltd. (3.59%), Allspring Global Investments Holdings LLC (3.18%) and Victory Capital Management Inc. (2.98%). Insiders that own company stock include Benaree Pratt Wiley, Chris Spurio, Jerome P Grisko, Joseph S Dimartino, Michael P Kouzelos, Rajesh Vashist, Sherrill W Hudson, Steven L Gerard, Todd J Slotkin and Ware H Grove.
View institutional ownership trends.

Shares of CBZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBZ stock can currently be purchased for approximately $50.16.

CBIZ (NYSE:CBZ) has a market capitalization of $2.53 billion and generates $1.47 billion in revenue each year. The business services provider earns $105.35 million in net income (profit) each year or $2.34 on an earnings per share basis.

The company employs 6,500 workers across the globe.

CBIZ's mailing address is 6050 OAK TREE BOULEVARD SOUTH SUITE 500, CLEVELAND OH, 44131. The official website for the company is www.cbiz.com. The business services provider can be reached via phone at (216) 447-9000 or via fax at 216-447-9007.